Arcturus Therapeutics Holdings Inc. (ARCT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Arcturus Therapeutics Holdings Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Arcturus Therapeutics Holdings Inc. (ARCT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $319M. It trades at $12.07, up 7.48% today. Its overall quality score is 41 out of 100, ranked against the whole US market. 7 analysts' average target of $21.29 implies +76.4% from today's price. Kronos AI's 30-day forecast is +2.8% (5 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $21.29 |
| Low – high | $9.00 – $41.00 |
| Analysts | 7 |
| Upside to average | +76.4% |
Kronos AI 30-day forecast
| Expected close | $11.55 (+2.8%) |
| Likely range | −12.2% … +10.5% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 42 |
| Solvency | 77 |
| Growth | 3 |
| Overall | 41 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator